Nurse Practitioner, Family · East Chicago, IN
NPI
1790208197
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4320 Fir St Unit 417
East Chicago, IN, 46312
Phone (219) 791-1555
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
217 services
Medicare patients, 2024
90
Average age 72
Drug cost, 2024
$585K
1,023 prescriptions
Company payments, 2025
$2,026
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melinda M Abbring was code 99214 (office e&m - established), 47 times for 36 patients. In total Melinda M Abbring billed 217 services in 13 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 47 | 36 | $49.46 | $2,324 |
| 99213 Office E&M - Established | Office | 41 | 33 | $34.39 | $1,410 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 38 | 22 | $181.04 | $6,880 |
By year: 2022 $32K for 346 services; 2023 $21K for 228 services; 2024 $15K for 217 services.
Medicare prescription drug claims, 2024
In 2024, the drug Melinda M Abbring prescribed most often to Medicare patients was Sevelamer Carbonate, with 169 prescriptions and refills. In total Melinda M Abbring wrote 1,023 Medicare prescriptions that cost $585K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 169 | 271 | 44 | $16K |
| Velphoro Sucroferric Oxyhydroxide | 92 | 110 | 26 | $309K |
| Amlodipine Besylate Generic | 68 | 154 | 25 | $217 |
| Calcitriol Generic | 53 | 95 | 16 | $728 |
| Renvela Sevelamer Carbonate | 44 | 46 | Under 11 | $59K |
| Carvedilol Generic | 44 | 86 | 18 | $129 |
| Auryxia Ferric Citrate | 35 | 49 | Under 11 | $79K |
| Atorvastatin Calcium Generic | 34 | 74 | 12 | $189 |
| Hydralazine Hcl Generic | 31 | 70 | 15 | $426 |
| Sertraline Hcl Generic | 28 | 52 | 11 | $48.03 |
| Furosemide Generic | 24 | 59 | 11 | $82.47 |
| Lanthanum Carbonate Generic | 20 | 24 | Under 11 | $14K |
| Doxazosin Mesylate Generic | 18 | 30 | Under 11 | $127 |
| Xphozah Tenapanor Hcl | 18 | 18 | Under 11 | $49K |
| Lokelma Sodium Zirconium Cyclosilicate | 16 | 26 | Under 11 | $14K |
Brand drugs: 251 claims; generic drugs: 772 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melinda M Abbring $2,026 ($2,026 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $361.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 17 | $361 |
| Ardelyx, Inc. ARDX | 17 | $330 |
| Fresenius USA Marketing, Inc. | 11 | $240 |
| Calliditas Therapeutics US Inc. | 7 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $171 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $155 |
| Travere Therapeutics, Inc. TVTX | 4 | $114 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $85.64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66.58 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $52.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.